Comparative Performance of PureVision, Acuvue Oasys and O2Optix
NCT ID: NCT00640341
Last Updated: 2011-12-12
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
510 participants
INTERVENTIONAL
2008-02-29
2008-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PureVision
PureVision Contact Lens
PureVision Contact Lens
contact lens for daily wear
Acuvue Oasys
Acuvue Oasys Contact Lens
Acuvue Oasys Contact Lens
contact lens for daily wear
O2Optix
O2Optix Contact Lens
O2Optix Contact lens
contact lens for daily wear
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PureVision Contact Lens
contact lens for daily wear
Acuvue Oasys Contact Lens
contact lens for daily wear
O2Optix Contact lens
contact lens for daily wear
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* VA correctable to 0.3 LogMAR or better (driving vision)
* Clear central cornea
* Subject uses a lens care system on a regular basis
Exclusion Criteria
* Using systemic or topical medications
* Wear monovision, multifocal or toric contact lenses
* Any grade 2 or greater slit lamp findings
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bausch & Lomb Incorporated
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gerard Cairns, MCOptom, PhD
Role: STUDY_DIRECTOR
Bausch & Lomb Incorporated
Bruce Anderson, OD
Role: PRINCIPAL_INVESTIGATOR
Anderson & Associates
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Anderson & Associates
Tampa, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
552
Identifier Type: -
Identifier Source: org_study_id